Xiaokan Zhang

1.3k total citations
22 papers, 974 citations indexed

About

Xiaokan Zhang is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiaokan Zhang has authored 22 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiaokan Zhang's work include RNA modifications and cancer (6 papers), RNA Research and Splicing (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Xiaokan Zhang is often cited by papers focused on RNA modifications and cancer (6 papers), RNA Research and Splicing (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Xiaokan Zhang collaborates with scholars based in United States, Germany and China. Xiaokan Zhang's co-authors include Frida E. Kleiman, P. Christian Schulze, Ruiping Ji, Michael Kim, Estíbaliz Castillero, Anders Virtanen, Peter J. Kennel, Danielle L. Brunjes, Xianghai Liao and Konstantinos Drosatos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Circulation.

In The Last Decade

Xiaokan Zhang

21 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaokan Zhang United States 15 744 227 181 145 91 22 974
Sahana Suresh Babu United States 13 381 0.5× 166 0.7× 107 0.6× 73 0.5× 71 0.8× 15 620
Ellen Dirkx Netherlands 15 632 0.8× 174 0.8× 322 1.8× 125 0.9× 209 2.3× 19 927
Ian M. Williams United States 14 428 0.6× 100 0.4× 164 0.9× 260 1.8× 101 1.1× 24 840
Traci Marin United States 16 589 0.8× 138 0.6× 89 0.5× 183 1.3× 133 1.5× 20 930
Kwan Hyuck Baek South Korea 5 584 0.8× 279 1.2× 92 0.5× 359 2.5× 68 0.7× 5 997
Outi Villet United States 11 423 0.6× 64 0.3× 263 1.5× 181 1.2× 86 0.9× 16 757
Jessica Ibetti United States 14 624 0.8× 116 0.5× 245 1.4× 101 0.7× 110 1.2× 22 772
Xue Ding China 15 619 0.8× 279 1.2× 101 0.6× 94 0.6× 181 2.0× 47 1.0k
Ana Ortega Spain 18 594 0.8× 231 1.0× 239 1.3× 41 0.3× 70 0.8× 45 851

Countries citing papers authored by Xiaokan Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaokan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaokan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaokan Zhang more than expected).

Fields of papers citing papers by Xiaokan Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaokan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaokan Zhang. The network helps show where Xiaokan Zhang may publish in the future.

Co-authorship network of co-authors of Xiaokan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaokan Zhang. A scholar is included among the top collaborators of Xiaokan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaokan Zhang. Xiaokan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morsink, Margaretha, et al.. (2025). The BAG3-HSP70-CHIP axis controls the degradation of TGFBR2 in cardiac fibroblasts. Journal of Molecular and Cellular Cardiology. 205. 13–23.
2.
Zhang, Xiaokan, et al.. (2022). Abstract 14981: Stk25 Regulates Cell Survival in Both Human and Mouse Models of Myocardial Injury. Circulation. 146(Suppl_1). 1 indexed citations
3.
Zhang, Xiaokan, Michael Kim, Trevor R. Nash, et al.. (2022). STK25 inhibits PKA signaling by phosphorylating PRKAR1A. Cell Reports. 40(7). 111203–111203. 6 indexed citations
4.
Kim, Michael & Xiaokan Zhang. (2019). The Profiling and Role of miRNAs in Diabetes Mellitus. PubMed. 1(1). 5–23. 77 indexed citations
5.
Carley, Andrew N., et al.. (2019). Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking. Circulation. 139(24). 2765–2777. 70 indexed citations
6.
Zhang, Xiaokan, Ruiping Ji, Xianghai Liao, et al.. (2018). MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation. Circulation. 137(19). 2052–2067. 147 indexed citations
7.
Kennel, Peter J., Raymond C. Givens, Danielle L. Brunjes, et al.. (2017). Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. The Journal of Heart and Lung Transplantation. 37(3). 409–417. 77 indexed citations
8.
Ji, Ruiping, Hirokazu Akashi, Konstantinos Drosatos, et al.. (2017). Increased de novo ceramide synthesis and accumulation in failing myocardium. JCI Insight. 2(9). 101 indexed citations
9.
Zhang, Xiaokan, et al.. (2017). Nucleolin phosphorylation regulates PARN deadenylase activity during cellular stress response. RNA Biology. 15(2). 251–260. 24 indexed citations
10.
Ji, Ruiping, Hirokazu Akashi, Konstantinos Drosatos, et al.. (2017). Increased de novo ceramide synthesis and accumulation in failing myocardium. JCI Insight. 2(14). 123 indexed citations
11.
Park, Ji Yeon, Michael R. Murphy, Xiaokan Zhang, et al.. (2016). Intronic cleavage and polyadenylation regulates gene expression during DNA damage response through U1 snRNA. Cell Discovery. 2(1). 16013–16013. 34 indexed citations
12.
Zhang, Xiaokan & P. Christian Schulze. (2016). MicroRNAs in heart failure: Non-coding regulators of metabolic function. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(12). 2276–2287. 23 indexed citations
13.
Zhang, Xiaokan, et al.. (2015). PARN deadenylase is involved in miRNA-dependent degradation of TP53 mRNA in mammalian cells. Nucleic Acids Research. 43(22). 10925–10938. 42 indexed citations
14.
Ji, Ruiping, Jennifer Y. Chang, Xianghai Liao, et al.. (2015). Abstract 17320: Inhibition of Ceramide Synthesis Preserves Cardiac Function and Increases Survival in Doxorubicin-induced Cardiomyopathy. Circulation. 132(suppl_3). 2 indexed citations
15.
Ji, Ruiping, Xianghai Liao, Xiaokan Zhang, et al.. (2015). Abstract 17347: De novo Ceramide Synthesis is Upregulated by Cardiac Ischemia and is Associated With Cardiomyocyte Apoptosis and Mitochondrial Dysfunction. Circulation. 132(suppl_3). 1 indexed citations
16.
Zhang, Xiaokan, Ruiping Ji, Xianghai Liao, et al.. (2014). Abstract 18978: Lysine Acetylation of Pyruvate Dehydrogenase Reduces Enzymatic Activity and Contributes to Impaired Substrate Metabolism in the Failing Myocardium. Circulation. 130(suppl_2). 1 indexed citations
17.
Zhang, Xiaokan, et al.. (2014). Deadenylation and Its Regulation in Eukaryotic Cells. Methods in molecular biology. 289–296. 3 indexed citations
18.
Zhang, Xiaokan, et al.. (2013). Positive and negative feedback loops in the p53 and mRNA 3′ processing pathways. Proceedings of the National Academy of Sciences. 110(9). 3351–3356. 42 indexed citations
19.
Cevher, Murat, Xiaokan Zhang, Sully Fernandez, et al.. (2010). Nuclear deadenylation/polyadenylation factors regulate 3′ processing in response to DNA damage. The EMBO Journal. 29(10). 1674–1687. 65 indexed citations
20.
Zhang, Xiaokan, Anders Virtanen, & Frida E. Kleiman. (2010). To polyadenylate or to deadenylate. Cell Cycle. 9(22). 4437–4449. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026